top of page

Thyrocare Technologies Ltd

  • Writer: Rajib Kar
    Rajib Kar
  • Mar 25
  • 2 min read

ree

Thyrocare Technologies Ltd. was established in 1996 by A. Velumani. They serve their products in Middle Eastern countries like Nepal, Bangladesh, etc. Their products are vitamins & nutrition, sexual wellness, pain relief, fitness supplements, etc. It has an employee base of around 1,693 people, working under the technical supervision of Rahul Guha (Chairman, CEO, and MD). API Holdings is the parent company of Thyrocare Technology.


Company Address:

Industrial Estate, B-42, Allauddin Basthi, Sanath Nagar, Hyderabad, Telangana 500018


Thyrocare Financial:

Income:

70.76 cr

Revenue:

581.64 cr

Asset:

278 cr

Cash flow:

106 cr

Dividend Yield:

2.57%

Liability:

90.48 cr

Market Cap:

3,835 cr

PE Ratio:

42.29

Debt to equity:

0.04

EPS:

17.56

PB Ratio:

7.01

ROE:

13.87%

 

Shareholding pattern:

Promoter

71.06%

Mutual Fund

12.75%

FII

2.77%

Other domestic institutions

1.93%

Retail & others

11.49%

 

Annual Report (2023-24)

Open this PDF to check the annual report of this company.


Latest News:


Corporate Social Responsibility (CSR):

Our CSR Philosophy is based on the principle of

“EMPOWERING AND ENABLING COMMUNITIES TO PARTICIPATE IN THE MARCH TOWARDS A BETTER TOMORROW.”


Mission:

To help exploit renewable energy sources and preserve natural resources.

• To help provide educational facilities to the under-privileged.

• To help improve infrastructural facilities, particularly in the rural areas.

• To contribute towards eradication of hunger, poverty, malnutrition, pollution and diseases.

• To contribute towards improvement of drinking water availability, medical facilities,

sanitation facilities, transportation facilities and educational facilities.

• To provide a helping hand to those who become victims of the fury of Nature.


Vision:

Our Vision is

“TO CONTRIBUTE AND STRIVE FOR A BETTER ENVIRONMENT, A BETTER

ECONOMY, A BETTER SOCIETY AND A BETTER LIVING CONDITION FOR THE

FELLOW CITIZENS.”

 

Up-coming projects:


Stock buying and selling price:

Thyrocare Technologies Ltd has shown over 30% growth in the last one year. Its stock price was at its peak in June 2021. The stock which was 1448.10 during the mid of 2021 is now at 733.5. Hopefully the stock price will reach above 900 in 2025. We will not be able to give the exact time when you should buy this stock, but we suggest you to buy the stocks of Thyrocare Technologies Ltd when it comes down to 650 or below. Hence, you are requested to sell it when the stock price is 865 or above.

Buy

Sell

650 or below

865 or above

 

Comments


Subscribe for latest updates • Don’t miss out!

Our Details

© 2035 by Unsold 70

Build a future-ready portfolio with Unsold70

Here is a Gateway of becoming a smart and informed stock market investor. At Unsold70, we bring you powerful stock market basics and a selected list of best 70 companies that are worth investing in. No matter you are a beginner or an experienced investor, our research-driven stock market news helps you uncover undervalued stocks with high growth potential.

 

Our team analyzes the trends, financials, and market movements to provide clear, actionable advice for confident investing. If you have the question how to invest in stock market in your mind, stay ahead with our expert updates, performance tracking, and real-time stock signals.

 

We refine our top 70 list regularly as per the recent stock market changes. Hence, we try to help the investors building a strong, stable, and future-ready portfolio. The right picks today can shape your financial success tomorrow. Explore smarter ways to invest and grow your wealth.

bottom of page